Insulin Degludec Versus Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes

Bernard Zinman, Athena Philis‐Tsimikas, Bertrand Cariou, +5

Diabetes Care

The Efficacy and Safety of Insulin Degludec Given in Variable Once-Daily Dosing Intervals Compared With Insulin Glargine and Insulin Degludec Dosed at the Same Time Daily

Luigi Meneghini, Stephen L. Atkin, Stephen Gough, +6

Diabetes Care

Insulin Degludec in Type 1 Diabetes

Kåre I. Birkeland, Philip Home, Ulrich Wendisch, +8

Diabetes Care

Insulin degludec, an ultra-long-acting basal insulin, once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes: a 16-week, randomised, open-label, phase 2 trial

Bernard Zinman, Greg Fulcher, Paturi Vishnupriya Rao, +8

The Lancet

Diabetes ManagementInsulin DegludecDiabetesInsulin ManagementType 2 +5

The obese Göttingen minipig as a model of the metabolic syndrome: dietary effects on obesity, insulin sensitivity, and growth hormone profile.

Thue Johansen, Harald S. Hansen, Bjørn Richelsen, +1

PubMed

NutritionMetabolic DisorderObesityMetabolic SyndromeBody Composition +14

Efficacy and safety of insulin degludec three times a week versus insulin glargine once a day in insulin-naive patients with type 2 diabetes: results of two phase 3, 26 week, randomised, open-label, treat-to-target, non-inferiority trials

Bernard Zinman, J. Hans DeVries, Bruce W. Bode, +5

The Lancet Diabetes & Endocrinology

Diabetes ManagementInsulin-naive PatientsInsulin ManagementDiabetesType 2 +5

Improved health status with insulin degludec compared with insulin glargine in people with Type 1 diabetes

Philip Home, Luigi Meneghini, Ulrich Wendisch, +6

Diabetic Medicine

Growth hormone affects both adiposity and voluntary food intake in old and obese female rats

Kjell Malmlöf, Nizam Ud Din, Thue Johansen

European Journal of Endocrinology

Growth Hormone-Mediated Breakdown of Body Fat: Effects of GH on Lipases in Adipose Tissue and Skeletal Muscle of Old Rats Fed Different Diets

Thue Johansen, Bjørn Richelsen, Harald S. Hansen, +2

Hormone and Metabolic Research

NutritionLipid StorageInsulin SignalingObesityMetabolic Syndrome +19

Effect of the cannabinoid receptor-1 antagonist rimonabant on lipolysis in rats

Signe Mølhøj, Harald S. Hansen, Martina Schweiger, +3

European Journal of Pharmacology

Cannabis UseFunctional SelectivityMedicineExperimental PharmacologyPharmacology +3